Novo Nordisk

Company NVO

Last mentioned: 3h ago

Timeline

Jan 1, 2027
Price Cut Effective

Novo Nordisk's 50% list price reduction for Ozempic and Wegovy takes effect.
Jan 1, 2026
Negotiation Deadline

Expected announcement of final negotiated prices for the first round of Medicare drugs.
Sep 24, 2024
Senate Hearing

Novo Nordisk CEO Lars Fruergaard Jørgensen testifies on high U.S. drug prices.
Aug 16, 2022
IRA Signed

Inflation Reduction Act grants CMS authority to negotiate drug prices.

Stories mentioning Novo Nordisk 1

Novo Nordisk to Slash Ozempic and Wegovy List Prices by 50% in 2027

Novo Nordisk has announced a significant reduction in the list prices for its blockbuster GLP-1 drugs, Ozempic and Wegovy, effective in 2027. The move, which could see prices drop by up to 50%, comes amid intense political pressure and federal negotiations aimed at lowering healthcare costs for American consumers.

3h ago 2 sources